Multicenter Studies as Topic
"Multicenter Studies as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.
| Descriptor ID |
D015337
|
| MeSH Number(s) |
E05.318.760.658 N05.715.360.775.508 N06.850.520.450.643
|
| Concept/Terms |
Multicenter Trials- Multicenter Trials
- Multicenter Trial
- Trial, Multicenter
- Trials, Multicenter
- Multicentre Trials
- Multicentre Trial
- Trial, Multicentre
- Trials, Multicentre
|
Below are MeSH descriptors whose meaning is more general than "Multicenter Studies as Topic".
Below are MeSH descriptors whose meaning is more specific than "Multicenter Studies as Topic".
This graph shows the total number of publications written about "Multicenter Studies as Topic" by people in this website by year, and whether "Multicenter Studies as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 5 | 5 |
| 1997 | 1 | 1 | 2 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 4 | 4 |
| 2002 | 0 | 4 | 4 |
| 2003 | 1 | 6 | 7 |
| 2004 | 0 | 12 | 12 |
| 2005 | 0 | 4 | 4 |
| 2006 | 0 | 9 | 9 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 6 | 7 |
| 2009 | 1 | 5 | 6 |
| 2010 | 0 | 3 | 3 |
| 2011 | 0 | 3 | 3 |
| 2012 | 1 | 2 | 3 |
| 2013 | 1 | 11 | 12 |
| 2014 | 1 | 6 | 7 |
| 2015 | 0 | 3 | 3 |
| 2016 | 1 | 2 | 3 |
| 2017 | 0 | 3 | 3 |
| 2018 | 2 | 8 | 10 |
| 2019 | 1 | 13 | 14 |
| 2020 | 1 | 13 | 14 |
| 2021 | 1 | 5 | 6 |
| 2022 | 0 | 17 | 17 |
| 2023 | 0 | 15 | 15 |
| 2024 | 1 | 8 | 9 |
| 2025 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Multicenter Studies as Topic" by people in Profiles.
-
The impact of liver transplantation on endpoint selection in alcohol-associated hepatitis trials. Hepatol Commun. 2025 May 01; 9(5).
-
Early nintedanib deployment in COVID-19 interstitial lung disease (ENDCOV-I): study protocol of a randomised, double-blind, placebo-controlled trial. BMJ Open Respir Res. 2025 Apr 10; 12(1).
-
Protocol for a multisite, observational clinical study of the association between skin colour and pulse oximeter accuracy in children undergoing cardiac catheterisation (PACH study). BMJ Open. 2025 Apr 05; 15(4):e100391.
-
Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial. BMJ Open Gastroenterol. 2025 Mar 31; 12(1).
-
Improving Maternal Postpartum Access to Care through Telemedicine (IMPACT): A multi-center randomized controlled trial of postpartum interventions to improve access and outcome. Contemp Clin Trials. 2025 May; 152:107882.
-
Let the resident try: Evaluation of central venous catheter placement in patients with hypotensive trauma using trauma video review. Surgery. 2025 05; 181:109215.
-
Young, Empowered & strong (YES): a study protocol paper for a randomized controlled trial of an mHealth symptom monitoring and self-management intervention for adolescent and young adult (AYA) breast cancer survivors. BMC Public Health. 2025 Jan 11; 25(1):126.
-
Preoperative estimated glomerular filtration rate to predict cardiac events in major noncardiac surgery: a secondary analysis of two large international studies. Br J Anaesth. 2025 Feb; 134(2):297-307.
-
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE?). Qual Life Res. 2025 Feb; 34(2):495-507.
-
Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints. J Cardiovasc Magn Reson. 2025 Summer; 27(1):101121.